JACOBS LEVY EQUITY MANAGEMENT, INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$12,254,000
-16.2%
704,024
-19.0%
0.13%
-19.6%
Q2 2020$14,623,000
+146.9%
869,400
+74.5%
0.16%
+107.9%
Q1 2020$5,923,000
+564.8%
498,130
+910.2%
0.08%
+375.0%
Q4 2017$891,000
+133.2%
49,310
+148.9%
0.02%
+128.6%
Q3 2017$382,000
+526.2%
19,810
+22.3%
0.01%
+600.0%
Q3 2015$61,00016,2000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,951,077$178,226,0009.95%
Parallel Advisors, LLC 3,769,455$96,649,0004.45%
Novo Holdings A/S 3,327,768$85,324,0004.07%
TANAKA CAPITAL MANAGEMENT INC 35,539$911,0002.72%
Quantedge Capital Pte Ltd 243,712$6,249,0001.93%
S&T BANK/PA 349,456$8,960,0001.73%
Birchview Capital, LP 50,000$1,282,0000.90%
Bridge City Capital, LLC 61,254$1,571,0000.86%
FAS Wealth Partners, Inc. 299,576$7,681,0000.85%
AJ WEALTH STRATEGIES, LLC 509,934$13,075,0000.76%
View complete list of CORCEPT THERAPEUTICS INC shareholders